investigational oral

Related by string. Investigational Oral * Investigational : Investigational Device Exemption IDE . investigational compound / ORAL : TULSA Okla. Oral Roberts * investigational oral antiplatelet . investigational oral Factor Xa . investigational oral inhibitor . investigational oral hepatitis C . investigational oral therapy . investigational oral anticoagulant *

Related by context. All words. (Click for frequent words.) 74 inhaled corticosteroid ICS 73 investigational compound 71 orally administered 71 long acting muscarinic 71 orally bioavailable 70 polymerase inhibitor 70 inhaled formulation 70 Laquinimod 70 sodium glucose cotransporter 70 angiotensin receptor blocker ARB 70 angiotensin II receptor blocker 69 investigational drug 69 nucleoside analog 69 PDE4 inhibitor 69 mTOR inhibitor 69 serotonin norepinephrine reuptake inhibitor 69 receptor antagonist 69 PSN# [002] 69 sorafenib tablets 68 ADP receptor antagonist 68 BAY #-# 68 DU #b 68 subcutaneously administered 68 oral formulation 68 SCH # 68 immunomodulator 68 small molecule Hedgehog 68 dipeptidyl peptidase 4 68 administered subcutaneously 68 acting muscarinic antagonist 68 Dapagliflozin 68 investigational humanized monoclonal antibody 68 multi kinase inhibitor 68 oral prodrug 68 investigational oral inhibitor 67 selective inhibitor 67 antagonist LAMA 67 liposomal formulation 67 long acting beta2 67 visilizumab 67 injectable formulation 67 diabetic neuropathic pain 67 nucleotide analogue 67 virus HCV protease inhibitor 67 selective antagonist 67 agonist LABA 67 forodesine 67 erlotinib Tarceva ® 67 oral anticoagulant 67 developing Bicifadine serotonin 67 anti muscarinic 67 injectable investigational 67 antimuscarinic agent 67 relapsing remitting multiple sclerosis 66 orally administered inhibitor 66 PNP inhibitor 66 orally administered immunomodulatory 66 highly selective inhibitor 66 beta2 agonist 66 nucleoside reverse transcriptase inhibitor 66 xanthine oxidase inhibitor 66 angiogenesis inhibitor 66 selective modulator 66 subcutaneous formulation 66 peripherally acting 66 intranasal formulation 66 dasatinib Sprycel ® 66 phase IIb clinical 66 Phase 1b trial 66 IMiDs R 66 ritonavir boosted 66 anticancer compound 66 investigational protease inhibitor 66 transcriptase inhibitor NNRTI 66 Mipomersen 66 sorafenib Nexavar 66 6R BH4 65 dihydrochloride 65 norepinephrine reuptake inhibitor 65 pan HDAC inhibitor 65 HCV protease inhibitor 65 non nucleoside inhibitor 65 CCR5 antagonist 65 MAGE A3 ASCI 65 Tarceva TM 65 pan histone deacetylase 65 insulin sensitizer 65 receptor agonist 65 Denufosol 65 Blinatumomab 65 abacavir lamivudine 65 topical gel formulation 65 Belimumab 65 somatostatin analogue 65 inhalation powder 65 TMC# C# 65 Eltrombopag 65 MTP inhibitor 65 Hsp# Inhibitor 65 Telmisartan 65 Talabostat 65 oral antiviral 65 angiotensin receptor blocker 65 albiglutide 65 oral dihydropyrimidine dehydrogenase DPD 65 reuptake inhibitor 65 Nexavar ® 65 orally inhaled 65 evaluating tivozanib 65 Safinamide 65 Rotigotine 65 Tolvaptan 65 Elvitegravir 65 2 methoxyestradiol 65 NVA# 65 fluticasone furoate 65 alkylating agent 65 Known generically 64 Ambrisentan 64 Vidaza azacitidine 64 acetylcholinesterase inhibitor 64 Adalimumab 64 Tanespimycin 64 intravitreal insert 64 blinded randomized placebo controlled 64 immunomodulatory therapy 64 oral renin inhibitor 64 laropiprant 64 Elesclomol 64 PRTX 64 DPP4 inhibitor 64 MEK inhibitor 64 nucleoside analogue 64 phase IIb trial 64 integrase inhibitor 64 histone deacetylase HDAC inhibitor 64 docetaxel Taxotere R 64 Fingolimod 64 VEGFR2 inhibitor 64 Aflibercept 64 sunitinib malate 64 beta 1a 64 octreotide acetate 64 lomitapide 64 Exenatide 64 investigational pharmacologically unique 64 diarrhea predominant irritable 64 Darusentan 64 PREZISTA r 64 LY# [002] 64 PRT# 64 Traficet EN 64 Maribavir 64 Panzem R 64 PPAR gamma agonist 64 HGS# 64 atypical antipsychotic 64 generation purine nucleoside 64 Febuxostat 64 selective agonist 64 IMiDs ® 64 edoxaban 64 investigational pan BCR 64 humanized monoclonal antibody 64 Sitagliptin 64 vidofludimus 64 potent CYP#A# inhibitors 64 Methylnaltrexone 64 Silodosin 64 opioid receptor antagonist 64 fumarate 64 JAK inhibitor 64 hour bronchodilation 64 TNF Tumor Necrosis Factor 64 protease inhibitor PI 64 NMDA antagonist 64 BRIM2 64 Tasigna nilotinib 64 novel histone deacetylase 64 Phase 2a clinical 64 Saxagliptin 64 PEGylated Fab fragment 64 SNRI 64 lipoglycopeptide 64 Linagliptin 64 enzyme inhibitor 63 FOLOTYN ® 63 Pazopanib 63 topiramate Topamax 63 ferric citrate 63 primary hypercholesterolemia 63 HFA MDI 63 MAP# 63 Atripla combines 63 Pathway Inhibitor 63 Tocilizumab 63 vascular disrupting agent 63 LIALDA 63 Sustiva efavirenz 63 QD dosing 63 neuraminidase inhibitor 63 antifungal agent 63 metformin HCl 63 mGluR5 negative 63 CEQ# 63 IAP inhibitor 63 selective estrogen receptor 63 methylnaltrexone bromide 63 boosted protease inhibitor 63 direct renin inhibitor 63 Sapacitabine 63 insulin sensitizers 63 Omacetaxine 63 kinase inhibitor 63 rhIGF-I/rhIGFBP-3 63 indacaterol 63 dopamine receptor agonist 63 Tezampanel 63 Vaprisol 63 metaglidasen 63 tenofovir Viread 63 anti TNF alpha 63 GW# [003] 63 Edoxaban 63 trospium chloride 63 imatinib Gleevec ® 63 pegylated interferon alfa 2a 63 HCV NS5B polymerase 63 Orally administered 63 oral hydromorphone 63 INVANZ 63 PEGylated anti 63 PKC# 63 receptor tyrosine kinase inhibitor 63 eltrombopag 63 FTY# fingolimod 63 Tyrima 63 oral rivaroxaban 63 teriflunomide 63 safety tolerability pharmacokinetics 63 Carfilzomib 63 indinavir Crixivan 63 HMG CoA reductase inhibitors 63 ALKS 63 Rivaroxaban 63 reversible inhibitor 63 ZOLINZA 63 Onglyza saxagliptin 63 Dabigatran etexilate 63 Enzastaurin 63 metastatic castration resistant 63 small molecule glucokinase 63 pertuzumab 63 #mg/#mg 63 orally dosed 63 investigational 63 pregabalin Lyrica 63 AAG geldanamycin analog 63 Luteinizing Hormone Releasing Hormone 63 MKC# MKC# PP 63 receptor modulator 63 AEGR 63 pioglitazone HCl 63 endothelin receptor antagonist DARA 63 Cetrorelix pamoate 63 Naproxcinod 63 antidepressant trazodone 63 Inhalation Powder 63 oral ridaforolimus 63 castrate resistant prostate cancer 63 NR2B selective 63 oral antidiabetic 62 severe gastroparesis 62 ascending dose study 62 therapeutically inactive prodrug 62 CG# [003] 62 intravenously administered 62 anticancer agent 62 novel topoisomerase 62 adalimumab Humira 62 Voreloxin 62 inhibitor PPI 62 sapropterin dihydrochloride 62 thiazolidinedione TZD 62 Mg Uk 62 subcutaneous SC 62 oral nucleoside analogue 62 fostamatinib 62 investigational hepatitis C 62 potent inhibitor 62 relapsed refractory multiple myeloma 62 CYC# 62 cell lymphoma CTCL 62 Omacetaxine mepesuccinate 62 angiotensin II receptor antagonist 62 Extended Release Tablets 62 aripiprazole Abilify 62 neuroprotective properties 62 Dasatinib 62 Mg Usa 62 mild vasodilator 62 lintuzumab SGN 62 #HT# 62 quetiapine fumarate 62 selective kinase inhibitor 62 candesartan cilexetil 62 Mirapexin 62 multicenter Phase II 62 Pharmacokinetics PK 62 active comparator 62 AKT inhibitor 62 metformin sulfonylurea 62 administered orally 62 Rebif ® 62 pharmacokinetic profile 62 Vandetanib 62 lamivudine 3TC 62 antiplatelet agent 62 Lubiprostone 62 PRX # 62 oral antifungal 62 PD LID 62 ALK inhibitor 62 vinca alkaloid 62 label multicenter Phase 62 adjunctive therapy 62 selective A2A adenosine receptor 62 Pegasys ® 62 Degarelix 62 cathepsin K inhibitor 62 LY# [003] 62 Clevudine 62 proteasome inhibitor 62 NXL# 62 alfa 2a 62 interferon gamma 1b 62 tenofovir emtricitabine 62 dexlansoprazole 62 mertansine 62 Phase Ib clinical trials 62 factor Xa inhibitor 62 reslizumab 62 formoterol fumarate 62 sunitinib Sutent ® 62 topically applied SEPA 62 Zoraxel TM 62 alvespimycin 62 selective phosphodiesterase 62 Teriflunomide 62 LEXIVA 62 rALLy clinical trial 62 Zoraxel 62 pharmacokinetics PK 62 Phase Ib clinical 62 metastatic hormone refractory 62 pseudobulbar affect PBA 62 D aspartate NMDA receptor 62 luteinizing hormone releasing 62 Certolizumab pegol 62 developing Zerenex ferric 62 axitinib 62 alefacept 62 mg administered orally 62 investigational antiplatelet agent 62 vapreotide acetate 62 TG# [003] 62 opioid analgesic 62 ulimorelin 62 temsirolimus 62 opioid antagonist 62 Toctino ® alitretinoin 62 YONDELIS 62 mitogen activated ERK kinase 62 Pagoclone 62 Inhalation Aerosol 62 memantine HCl 62 Roflumilast 62 Phase 2b clinical 62 ACTEMRA TM 62 brand ciclesonide HFA 62 tolerated dose MTD 62 rivastigmine Exelon 62 VAPRISOL 62 pyrimidine nucleoside analog 62 Phase #b/#a clinical 62 tiotropium bromide 62 Pegloticase 62 Microplasmin 62 rHuPH# recombinant human 62 Diabetic Macular Edema DME 62 selectively inhibits 62 tablet formulation 62 Initiate Phase 62 ramipril Altace 61 mometasone 61 opioid induced bowel dysfunction 61 Nitazoxanide 61 Bucindolol 61 fosbretabulin 61 peginterferon alfa 2b 61 BYETTA ® 61 relapsed multiple myeloma 61 immunomodulating 61 paclitaxel Taxol 61 Phase 2a trial 61 Phase 2b clinical trials 61 Cloretazine 61 immunosuppressant drug 61 leukotriene receptor antagonist 61 small molecule inhibitor 61 mesylate 61 safety tolerability pharmacokinetic 61 PEG Interferon lambda 61 alpha blocker 61 Annamycin 61 echinocandin 61 insulin sensitizing 61 etanercept Enbrel 61 beclomethasone dipropionate 61 mixed dyslipidemia 61 GLPG# 61 losartan potassium 61 APTIVUS 61 tezampanel 61 Paxil paroxetine 61 BMS # 61 Inhalation Solution 61 novel oral anticoagulant 61 laquinimod 61 anti amnesic 61 relapsing multiple sclerosis 61 post herpetic neuralgia PHN 61 SPD# 61 nab paclitaxel 61 oral isoform selective HDAC 61 rNAPc2 61 modulator SERM 61 Linaclotide 61 selective adhesion molecule 61 HSP# inhibitor 61 RANK Ligand inhibitor 61 Phase Ib II 61 alpha 2A 61 Cyclooxygenase Inhibiting Nitric Oxide 61 Prulifloxacin 61 dose escalation trial 61 dyskinesia PD LID 61 cetuximab Erbitux R 61 thetreatment 61 nilotinib Tasigna ® 61 oral ghrelin agonist 61 desvenlafaxine succinate 61 Ofatumumab 61 refractory chronic lymphocytic 61 Zorbtive TM 61 LymphoStat B TM 61 partial agonist 61 receptor partial agonist 61 albinterferon alfa 2b 61 Amrubicin 61 investigational monoclonal antibody 61 IMC A# 61 Phase 1b clinical 61 HCV protease 61 PTH1 61 direct thrombin inhibitor 61 HCD# [002] 61 Valsartan 61 regorafenib 61 Alinia 61 selective androgen receptor modulator 61 oral iron chelator 61 transdermal spray 61 Kinesin Spindle Protein KSP 61 REVLIMID lenalidomide 61 oral protease inhibitor 61 Irinotecan 61 Ropinirole 61 induced macular edema 61 Paliperidone Palmitate 61 Seliciclib 61 raloxifene Evista 61 topically administered 61 pharmacodynamic profile 61 delta opioid receptor 61 itraconazole Sporanox 61 exenatide injection 61 agonist 61 rosiglitazone maleate 61 novel VDA molecule 61 Phase IIa trial 61 panitumumab Vectibix 61 systemic juvenile idiopathic 61 pharmacodynamic properties 61 Sym# 61 rheumatoid arthritis psoriatic arthritis 61 hepatitis C protease inhibitor 61 CDP# 61 Xeloda ® 61 salmeterol fluticasone 61 Horizant ™ 61 amprenavir 61 Phase IIb clinical 61 plus prednisone prednisolone 61 muraglitazar 61 ongoing Phase 1b 61 Romiplostim 61 Factor Xa inhibitor 61 tipifarnib 61 tenofovir disoproxil fumarate 61 fluticasone propionate 61 * olmesartan medoxomil 61 direct Factor Xa 61 potent topoisomerase II 61 human rDNA origin 61 prokinetic agent 61 CYP#A# CYP#D# 61 Phase 2b study 61 TELINTRA 61 small molecule thrombopoietin 61 fluoroquinolone antibiotic 61 valsartan Diovan 61 Oral Spray 61 PDE5 inhibitor 61 INCB# [001] 61 ketolide antibiotic 61 ULORIC 61 Actemra tocilizumab 61 DDP# 61 Randomized Phase 61 oropharyngeal candidiasis OPC 61 placebo controlled Phase 61 oral Factor Xa 61 Quinamed 61 azilsartan medoxomil 61 Ciclesonide 61 Ceflatonin 61 atypical antipsychotic medication 61 generation Hsp# inhibitor 61 betrixaban 61 varespladib 61 aflibercept VEGF Trap 61 efavirenz EFV 61 Kuvan sapropterin dihydrochloride 61 Archexin 61 inhaled corticosteroid 61 Solulin 61 Bosutinib 61 neratinib 61 MT# MEDI 61 proton pump inhibitor PPI 61 Vilazodone 61 oral salmon calcitonin 61 ISENTRESS 61 Avanafil 61 gonadotropin releasing hormone GnRH 61 Elagolix 61 targeted antifolate 61 Bicalutamide 61 inhalations twice 61 CIMZIA TM 61 Phase IIa clinical 61 Ophena TM 61 Zileuton 61 BENICAR 61 Elotuzumab 61 hyperphenylalaninemia HPA due 61 INSPIRE Trial Phase III 61 double blinded placebo 61 receptor antagonists 61 metformin hydrochloride 61 use transdermal sumatriptan 61 signal transduction inhibitor 61 Asacol R 61 incretin mimetic 61 R roscovitine CDK cyclin 61 liposome injection 61 3TC lamivudine 61 PI3K/Akt pathway inhibitor 61 Oxytrex TM 61 AZILECT R 61 dasatinib Sprycel 61 humanized monoclonal 61 cutaneous T 61 receptor modulators 61 Afatinib 61 factor G CSF 61 protein kinase inhibitor 61 Investigational Oral 61 JANUVIA 61 unique alkylating agent 61 ergot derivatives 61 mometasone furoate 61 Pafuramidine 61 Lacosamide 61 Colesevelam 61 RELOVAIR ™ 61 terfenadine 61 Dimebon latrepirdine 61 antiepileptic drug 61 leukotriene receptor antagonists 61 Iloperidone 61 antibody MAb 61 moxifloxacin HCl 61 Trandolapril 61 refractory gout 61 Monopril 61 ipratropium bromide 61 Serdaxin ® 60 randomized controlled Phase 60 nucleotide analog 60 Exjade deferasirox 60 KSP inhibitor 60 oral immunomodulatory 60 evaluating carfilzomib 60 humanized anti 60 PDX pralatrexate 60 mg Tablets 60 dextromethorphan quinidine 60 chimeric monoclonal antibody 60 OAB overactive bladder 60 Gabapentin GR 60 DB# [003] 60 urate lowering 60 RezularTM 60 pomalidomide 60 factor TNF 60 HCV polymerase 60 subcutaneous dose 60 hormone LHRH antagonist 60 Oral NKTR 60 Taxol paclitaxel 60 Phase IIb Trial 60 FDA APPROVES 60 TBC# 60 targeting CD# 60 dopamine agonist 60 Pralatrexate 60 Temsirolimus 60 phase IIa clinical 60 Fc fusion protein 60 R sorafenib tablets 60 novel immunomodulatory 60 inhibitor 60 orally disintegrating 60 hypoxia inducible factor 60 Telavancin 60 thiazolidinedione 60 delivers fluocinolone acetonide FA 60 ISENTRESS raltegravir 60 anti androgen 60 prucalopride 60 R lenalidomide 60 MIRCERA 60 vandetanib 60 Indacaterol 60 bevacizumab Avastin ® 60 RDEA# 60 NOXAFIL 60 Plicera 60 valent conjugate vaccine 60 overactive bladder OAB 60 combines bupropion 60 formerly LymphoStat B 60 ISIS # 60 olmesartan 60 phase Ib 60 Abiraterone acetate 60 valsartan amlodipine 60 sertraline Zoloft 60 somatostatin analog 60 Copegus ribavirin 60 ORENCIA ® 60 Taxotere docetaxel 60 investigational integrase inhibitor 60 ZD# [001] 60 MMX mesalamine 60 orally inhaled migraine 60 PROVENGE sipuleucel T 60 SAR# [004] 60 Galantamine 60 anti angiogenic agent 60 CIMZIA TM certolizumab pegol 60 PEGylated interferon beta 1a 60 lapatinib Tykerb 60 JAK2 inhibitor 60 sulodexide 60 Pegasys R 60 EFFEXOR XR 60 Daclizumab 60 LAF# 60 interferon alfa 2b 60 Bezielle 60 Motesanib 60 oral anti arrhythmic 60 aliskiren amlodipine 60 depsipeptide 60 VA# [002] 60 Saizen ® 60 systemic RNAi therapeutic 60 Tipranavir 60 Ridaforolimus 60 2A receptor agonist 60 zileuton 60 oral deforolimus 60 KRN# 60 intermittent dosing 60 oral proteasome inhibitor 60 humanized interleukin 6 60 small molecule chemotherapeutic 60 XL# anticancer compounds 60 Angiotensin Converting Enzyme 60 posaconazole 60 Lixisenatide 60 Melphalan 60 orally disintegrating tablet 60 immunomodulatory 60 Interferon beta 1b 60 diclofenac sodium 60 dipeptidyl peptidase IV 60 pramlintide 60 ciprofloxacin hydrochloride 60 meropenem 60 TO AVOID PREGNANCY WHILE 60 metformin sulfonylureas 60 mGluR2 positive 60 immune modulator 60 Bevirimat 60 Desmopressin 60 CDK inhibitor 60 docetaxel Taxotere 60 orally disintegrating tablets 60 Dalbavancin 60 peptibody 60 APEX PD 60 Pimavanserin 60 nitazoxanide 60 teplizumab 60 tolerability profile 60 pegylated 60 Lu AA# 60 Gel repository corticotropin injection 60 BCR ABL inhibitors 60 Cycloset 60 paliperidone palmitate 60 controlled multicenter 60 Peg IFN 60 irreversible inhibitor 60 tasocitinib 60 HGS ETR2 60 hypoxia activated prodrug 60 administered intranasally 60 R bisoprolol Euthyrox 60 prodrug 60 Perifosine 60 novel prodrug 60 IMiDs ® compound 60 bortezomib Velcade R 60 advanced metastatic renal 60 miconazole 60 NKTR 60 Trimesta 60 azilsartan 60 Romidepsin 60 antifibrotic 60 Akt inhibitor 60 sphingosine 1 60 CRESTOR rosuvastatin calcium 60 Albuferon TM 60 5 HT3 antagonist 60 insulin aspart 60 adjunctive treatment 60 Darunavir 60 Phase IIb trial 60 retapamulin 60 HuMax EGFr 60 5 HT6 receptor 60 monotherapy 60 cetuximab Erbitux ® 60 Ticagrelor 60 Ziprasidone 60 Liraglutide 60 plus Copegus R 60 Tasimelteon 60 PI3K inhibitor 60 R metformin Concor 60 granisetron 60 selective serotonin 2C receptor 60 ganetespib 60 torezolid phosphate 60 topoisomerase II inhibitor 60 Metformin GR 60 ONGLYZA ™ 60 Epothilone D 60 drug pipeline TAFA# 60 small molecule tyrosine 60 acyclovir Lauriad R 60 olanzapine Zyprexa 60 targeted radiotherapeutic 60 AVONEX ® 60 Muraglitazar 60 non splenectomized 60 acting neuraminidase inhibitor 60 Emtriva emtricitabine 60 dalbavancin 60 selective estrogen receptor modulator 60 Xanafide 60 phase IIb 60 rasagiline tablets 60 IgG1 monoclonal antibody 60 AEG# 60 highly selective endothelin 60 carbamazepine phenobarbital phenytoin rifampin 60 desvenlafaxine 60 ciclesonide 60 oral dosing 60 adenosine A2A 60 Meets Primary Endpoint 60 trabedersen 60 oral dual endothelin 60 Phase 1b 60 pegylated interferon alpha 60 humanized therapeutic 60 Iluvien ® 60 mGluR5 NAM 60 uric acid lowering 60 SGLT2 inhibitor 60 investigational atypical antipsychotic 60 alpha 2b 60 bendamustine 60 ibandronate 60 dexamethasone Decadron 60 Anturol TM 60 immunotherapeutic agent 60 Abilify aripiprazole 60 metformin XR 60 Golimumab 60 ceftazidime 60 inhaled formulations 60 oral Janus kinase 60 roflumilast 60 Alitretinoin 60 tartrate Inhalation Solution 60 Sodium oxybate 60 mTOR mammalian target 60 abacavir sulfate lamivudine 60 Dual Opioid 60 Reverset 60 atazanavir Reyataz 60 MKC# MT 60 Phase IIIb clinical 60 otelixizumab 60 docetaxel chemotherapy 60 clinical trials Archexin ® 60 Clolar ® 60 pharmacologically active isomer 60 medoxomil 60 q8h 60 levetiracetam Keppra 60 dexpramipexole 60 DFMO 60 sorafenib Nexavar R 59 Vidofludimus 59 dosed orally 59 non peptidic protease 59 ascending doses 59 RoACTEMRA 59 VELCADE melphalan 59 salmeterol inhalation powder 59 cilengitide 59 tocilizumab 59 herpetic keratitis 59 denileukin diftitox 59 guanfacine 59 Cetrorelix 59 acting injectable formulation 59 erlotinib Tarceva R 59 leukemia AML 59 pralatrexate injection folate analogue 59 PF # [001] 59 AVASTIN 59 class mGluR5 inhibitor 59 PEG SN# 59 olmesartan medoxomil 59 Lixivaptan 59 synthetic progestin 59 ethinyl estradiol tablets 59 Clonicel 59 HGS ETR1 mapatumumab 59 Hydroxyurea 59 icatibant 59 non nucleoside HCV 59 investigational transdermal 59 Lenalidomide 59 placebo controlled randomized 59 serotonin reuptake inhibitor 59 FOLFOX6 chemotherapy regimen 59 injectable antibiotic 59 Boceprevir 59 Alogliptin 59 Personalized Immunotherapy 59 Pegasys peginterferon alfa 2a 59 atrasentan 59 transdermal patch 59 Tesetaxel 59 abatacept Orencia 59 HuMax CD4 59 Fluticasone 59 brivanib 59 multicenter randomized placebo controlled 59 multicenter Phase III 59 metastatic renal cell carcinoma 59 pharmacodynamics 59 VICTOR E3 59 Sprycel dasatinib 59 TMC# [001] 59 oral antibiotic 59 Tiotropium 59 PHX# 59 mTOR kinase 59 IV bolus 59 GRALISE 59 SAR# [002] 59 immunosuppressant 59 systemic antifungal 59 NEBIDO R 59 Clofarabine 59 Raptiva R 59 RG# ITMN 59 dihydroergotamine 59 insulin degludec 59 mesylate tablets 59 Serostim ® 59 Liprotamase 59 pharmacokinetic interactions 59 Afinitor ® 59 L Annamycin 59 Granulocyte Colony Stimulating Factor 59 Nanobody 59 Montelukast 59 dependent kinase inhibitor 59 Aurora kinase inhibitor 59 Etravirine 59 SELZENTRY 59 Ixempra 59 MKC# 59 MEK Inhibitor 59 cyclobenzaprine hydrochloride extended 59 CIMZIA ™ 59 multicenter randomized 59 Bicifadine 59 Piperacillin 59 novel cardiac myosin 59 Oral Fingolimod 59 potent antiproliferative 59 adenosine injection 59 Epivir 59 dose escalation clinical 59 AIR CF1 59 Parkinson disease levodopa induced 59 lamivudine zidovudine 59 gemcitabine Gemzar 59 Phase 1a clinical 59 phase III isavuconazole 59 receptor inhibitor 59 Aztreonam 59 antidiabetic 59 Losartan Potassium 59 Medidur TM FA 59 docetaxel Taxotere ® 59 cortisol synthesis 59 darunavir Prezista 59 ROZEREM TM 59 Actonel risedronate 59 zidovudine AZT 59 ABL inhibitor 59 uncomplicated urinary tract infections 59 ® lenalidomide 59 Tofacitinib 59 oral transmucosal 59 ALVESCO R 59 multiple ascending dose 59 Panzem R NCD 59 interferon beta 1a 59 NeuroSTAT ® 59 EXPAREL TM 59 SRT# [003] 59 Omnitarg 59 Everolimus 59 investigational oral antiplatelet 59 Initiated Phase 59 Investigational Compound 59 R Saizen R 59 Pivotal Phase 59 mapatumumab 59 telaprevir dosed 59 Phase III randomized 59 Erlotinib 59 Pemetrexed

Back to home page